MS
Michael J. Sofia
Chief Scientific Officer

Michael J. Sofia insider trades: Arbutus Biopharma (ABUS) stock sales

Chief Scientific Officer, Arbutus Biopharma Last trade Feb 2, 2024 16 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
8
Open-market trades
since 2017
1
Company
last trade 2024

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Michael reports to the SEC

Open-market buys and sales

8 trades reported on SEC Form 4, newest first

DateStockTypeValue
Feb 2, 2024ABUS↓ Sell$23K
Dec 1, 2021ABUS↓ Sell$1.0M
Aug 13, 2018ABUS↓ Sell$40K
Jul 11, 2018ABUS↓ Sell$100K
Jul 9, 2018ABUS↓ Sell$174K
Jul 5, 2018ABUS↓ Sell$164K
Oct 3, 2017ABUS↓ Sell$80K
Aug 15, 2017ABUS↓ Sell$111K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Michael J. Sofia's insider trades

Michael J. Sofia is Chief Scientific Officer at Arbutus Biopharma (ABUS). Since Aug 15, 2017, Michael has reported no open-market purchases and 8 sales worth $1.7M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (9 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ABUS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.